Fluoreszcencia in situ hibridizációval szerzett tapasztalataink a krónikus myeloid leukaemia diagnosztikájában és követésében.

Translated title of the contribution: Fluorescence in situ hybridization in the diagnosis and follow-up of chronic myelogenous leukemia

L. Rejtó, M. Balázs, R. Ádány, K. Rák, B. Telek, A. Kiss, G. Ujj, G. Mezei, E. Balogh, M. Udvardy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chronic myelogenous leukaemia is a clonal myeloproliferative stem cell disease. Its cytogenetical hallmark is the Philadelphia chromosome (Ph) or the BCR/ABL fusion gene. Their identification is important both in the diagnosis and the follow-up of the disease. In our department we have investigated the BCR/ABL gene arrangement in 21 patients with fluorescence in situ hybridization. The aim of the analysis in freshly suspected patients without any previous therapy was to confirm diagnosis and mapping the ratio of Philadelphia positive cells. In contrast to the 95-100% Ph-positivity of mononuclear cells by classical cytogenetical examinations we found BCR/ABL gene arrangement only in various but always lower proportions. Therefore the latter examination gives a better representation of residual normal hemopoesis. Out of 9 patients who had received interferon treatment for at least 6 months, 4 gave a major, 4 a minor cytogenetical answer and in 1 case there was no cytogenetical response. Seven patients reached a complete and 2 a partial hematological remission. Among 5 other patients receiving interferon treatment, in 2 cases with double Ph-positivity we found a rapid progression. The data of 3 patients had to be excluded from the evaluation due to the so far short following time.

Original languageHungarian
Pages (from-to)2133-2137
Number of pages5
JournalOrvosi Hetilap
Volume141
Issue number39
Publication statusPublished - Sep 24 2000

Fingerprint

Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Fluorescence In Situ Hybridization
Gene Order
Interferons
Philadelphia Chromosome
Gene Fusion
Stem Cells
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fluoreszcencia in situ hibridizációval szerzett tapasztalataink a krónikus myeloid leukaemia diagnosztikájában és követésében. / Rejtó, L.; Balázs, M.; Ádány, R.; Rák, K.; Telek, B.; Kiss, A.; Ujj, G.; Mezei, G.; Balogh, E.; Udvardy, M.

In: Orvosi Hetilap, Vol. 141, No. 39, 24.09.2000, p. 2133-2137.

Research output: Contribution to journalArticle

Rejtó, L. ; Balázs, M. ; Ádány, R. ; Rák, K. ; Telek, B. ; Kiss, A. ; Ujj, G. ; Mezei, G. ; Balogh, E. ; Udvardy, M. / Fluoreszcencia in situ hibridizációval szerzett tapasztalataink a krónikus myeloid leukaemia diagnosztikájában és követésében. In: Orvosi Hetilap. 2000 ; Vol. 141, No. 39. pp. 2133-2137.
@article{376e7ff86af449e0ad69e90a0c7d582e,
title = "Fluoreszcencia in situ hibridiz{\'a}ci{\'o}val szerzett tapasztalataink a kr{\'o}nikus myeloid leukaemia diagnosztik{\'a}j{\'a}ban {\'e}s k{\"o}vet{\'e}s{\'e}ben.",
abstract = "Chronic myelogenous leukaemia is a clonal myeloproliferative stem cell disease. Its cytogenetical hallmark is the Philadelphia chromosome (Ph) or the BCR/ABL fusion gene. Their identification is important both in the diagnosis and the follow-up of the disease. In our department we have investigated the BCR/ABL gene arrangement in 21 patients with fluorescence in situ hybridization. The aim of the analysis in freshly suspected patients without any previous therapy was to confirm diagnosis and mapping the ratio of Philadelphia positive cells. In contrast to the 95-100{\%} Ph-positivity of mononuclear cells by classical cytogenetical examinations we found BCR/ABL gene arrangement only in various but always lower proportions. Therefore the latter examination gives a better representation of residual normal hemopoesis. Out of 9 patients who had received interferon treatment for at least 6 months, 4 gave a major, 4 a minor cytogenetical answer and in 1 case there was no cytogenetical response. Seven patients reached a complete and 2 a partial hematological remission. Among 5 other patients receiving interferon treatment, in 2 cases with double Ph-positivity we found a rapid progression. The data of 3 patients had to be excluded from the evaluation due to the so far short following time.",
author = "L. Rejt{\'o} and M. Bal{\'a}zs and R. {\'A}d{\'a}ny and K. R{\'a}k and B. Telek and A. Kiss and G. Ujj and G. Mezei and E. Balogh and M. Udvardy",
year = "2000",
month = "9",
day = "24",
language = "Hungarian",
volume = "141",
pages = "2133--2137",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "39",

}

TY - JOUR

T1 - Fluoreszcencia in situ hibridizációval szerzett tapasztalataink a krónikus myeloid leukaemia diagnosztikájában és követésében.

AU - Rejtó, L.

AU - Balázs, M.

AU - Ádány, R.

AU - Rák, K.

AU - Telek, B.

AU - Kiss, A.

AU - Ujj, G.

AU - Mezei, G.

AU - Balogh, E.

AU - Udvardy, M.

PY - 2000/9/24

Y1 - 2000/9/24

N2 - Chronic myelogenous leukaemia is a clonal myeloproliferative stem cell disease. Its cytogenetical hallmark is the Philadelphia chromosome (Ph) or the BCR/ABL fusion gene. Their identification is important both in the diagnosis and the follow-up of the disease. In our department we have investigated the BCR/ABL gene arrangement in 21 patients with fluorescence in situ hybridization. The aim of the analysis in freshly suspected patients without any previous therapy was to confirm diagnosis and mapping the ratio of Philadelphia positive cells. In contrast to the 95-100% Ph-positivity of mononuclear cells by classical cytogenetical examinations we found BCR/ABL gene arrangement only in various but always lower proportions. Therefore the latter examination gives a better representation of residual normal hemopoesis. Out of 9 patients who had received interferon treatment for at least 6 months, 4 gave a major, 4 a minor cytogenetical answer and in 1 case there was no cytogenetical response. Seven patients reached a complete and 2 a partial hematological remission. Among 5 other patients receiving interferon treatment, in 2 cases with double Ph-positivity we found a rapid progression. The data of 3 patients had to be excluded from the evaluation due to the so far short following time.

AB - Chronic myelogenous leukaemia is a clonal myeloproliferative stem cell disease. Its cytogenetical hallmark is the Philadelphia chromosome (Ph) or the BCR/ABL fusion gene. Their identification is important both in the diagnosis and the follow-up of the disease. In our department we have investigated the BCR/ABL gene arrangement in 21 patients with fluorescence in situ hybridization. The aim of the analysis in freshly suspected patients without any previous therapy was to confirm diagnosis and mapping the ratio of Philadelphia positive cells. In contrast to the 95-100% Ph-positivity of mononuclear cells by classical cytogenetical examinations we found BCR/ABL gene arrangement only in various but always lower proportions. Therefore the latter examination gives a better representation of residual normal hemopoesis. Out of 9 patients who had received interferon treatment for at least 6 months, 4 gave a major, 4 a minor cytogenetical answer and in 1 case there was no cytogenetical response. Seven patients reached a complete and 2 a partial hematological remission. Among 5 other patients receiving interferon treatment, in 2 cases with double Ph-positivity we found a rapid progression. The data of 3 patients had to be excluded from the evaluation due to the so far short following time.

UR - http://www.scopus.com/inward/record.url?scp=0034710780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034710780&partnerID=8YFLogxK

M3 - Article

C2 - 11028176

AN - SCOPUS:0034710780

VL - 141

SP - 2133

EP - 2137

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 39

ER -